Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Bial Portela & Cª, S.A., À Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal, Tel:+351 22 986 61 00, Fax: +351 22 986 61 90, e-mail: info@bial.com
Ontilyv 25 mg hard capsules.
Ontilyv 50 mg hard capsules.
Pharmaceutical Form |
---|
Hard capsule (capsule). Ontilyv 25 mg hard capsules: Light blue capsules, size 1, approximately 19 mm, imprinted “OPC 25” on the cap and “Bial” on the body. Ontilyv 50 mg hard capsules: Dark blue capsules, size 1, approximately 19 mm, imprinted “OPC 50” on the cap and “Bial” on the body. |
Each hard capsule contains 25 mg of opicapone.
Excipient(s) with known effect: Each hard capsule contains 171.9 mg of lactose (as monohydrate).
Each hard capsule contains 50 mg of opicapone.
Excipient(s) with known effect: Each hard capsule contains 148.2 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Opicapone |
Opicapone is a peripheral, selective and reversible catechol-O-methyltransferase (COMT) inhibitor endowed with a high binding affinity (sub-picomolar). Opicapone is indicated as adjunctive therapy to preparations of levodopa/DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinson’s disease, leading to an increase of levodopa plasma levels thereby improving the clinical response to levodopa. |
List of Excipients |
---|
Capsule content: Lactose monohydrate Capsule shell: Gelatin Printing ink: Ontilyv 25 mg hard capsules: Shellac Ontilyv 50 mg hard capsules: Shellac |
Ontilyv 25 mg hard capsules:
White high density polyethylene (HDPE) bottles with polypropylene (PP) child resistant closures containing 10 or 30 capsules.
OPA/Al/PVC//Al blisters containing 10 or 30 capsules.
Ontilyv 50 mg hard capsules:
White high density polyethylene (HDPE) bottles with polypropylene (PP) child resistant closures containing 10, 30 or 90 capsules.
OPA/Al/PVC//Al blisters containing 10, 30 or 90 capsules.
Not all pack sizes may be marketed.
Bial – Portela & Cª, S.A., À Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal, Tel:+351 22 986 61 00, Fax: +351 22 986 61 90, e-mail: info@bial.com
EU/1/21/1578/001-010
Drug | Countries | |
---|---|---|
ONTILYV | Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.